Early detection and innovative treatments to help boost gastrointestinal drug sales to $44 bn in 2010.

(From Chemical Business NewsBase - Press Release)

Advances in the detection and treatment of gastrointestinal (GI) disorders, as well as the wide acceptance of popular GI remedies by an aging population, will help the global market for gastrointestinal drugs increase by 9% over the next several years to surpass $44 bn by 2010. According to The Worldwide Market for Prescription Gastrointestinal Drugs, a new study released from Kalorama Information, growth is expected to continue for all segments as testing and therapeutic advancements continue to develop. Advanced treatments are expected to provide the cancer segment with the highest growth of 19.8%, followed by the …